Jaguar Animal Health (JAGX)
(Real Time Quote from BATS)
$2.07 USD
-0.16 (-6.97%)
Updated Aug 7, 2025 03:36 PM ET
After-Market: $2.10 +0.03 (1.45%) 4:08 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
JAGX 2.07 -0.16(-6.97%)
Will JAGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JAGX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for JAGX
12 Health Care Stocks Moving In Monday's Pre-Market Session
Jaguar Health (JAGX) Advances in Canalevia-CA1 Study for Dogs | JAGX Stock News
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 ...
Jaguar Health initiates enrollment in study of Canalevia-CA1 drug for dogs
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian ...